생명과학회지 (Journal of Life Science)

  • 제28권4호
  • /
  • Pages.465-471
  • /
  • 2018
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

테스토스테론-유도 양성전립선비대증에서 나노화 벌 화분의 효능 연구

Beneficial Effects of Nano-sized Bee Pollen on Testosterone-induced Benign Prostatic Hyperplasia in Rodents

  • Bak, Jia (Department of Pharmacy, Kyungsung University) ;
  • Pyeon, Hae-In (Department of Pharmacy, Kyungsung University) ;
  • So, Soojeong (Research Center, Natural Science Biotechnology Co., Ltd.) ;
  • Lee, Seunghyun (Department of Biotechnology, Daegu Catholic University) ;
  • Lee, Seungmin (Research Center, Natural Science Biotechnology Co., Ltd.) ;
  • Suh, Hwa-Jin (Research Center, Natural Science Biotechnology Co., Ltd.) ;
  • Kang, Jae Seon (Department of Pharmacy, Kyungsung University) ;
  • Choi, Yun-Sik (Department of Pharmacy, Kyungsung University) ;
  • Chung, Il Kyung (Department of Biotechnology, Daegu Catholic University)
  • 투고 : 2018.01.16
  • 심사 : 2018.04.04
  • 발행 : 2018.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

벌 화분은 오랫동안 전 세계적으로 이용되어 온 대체요법 중 하나이다. 벌 화분은 항진균 및 항균작용, 항암작용, 면역조절, 그리고 세포의 증식 등 다양한 생리활성을 갖고 있는 것으로 알려져 있다. 본 연구는 설치류를 이용하여 벌 화분의 양성전립선비대증의 개선 효과를 밝히기 위해 진행되었다. 벌 화분은 활성 성분의 추출률을 극대화하고, 생체 흡수율을 높이기 위하여 나노 크기로 분쇄하여 이용하였다. 먼저, 나노 크기의 벌 화분은 만성 testosterone 투여에 의한 전립선 크기 증가를 유의하게 완화하였다. 게다가 나노 크기의 벌 화분은 혈중 전립선 특이 항원의 농도를 뚜렷하게 감소시켰다. 흥미롭게도 나노 크기의 벌 화분은 testosterone에 의한 혈중 prostaglandin $E_2$ 증가에는 유의한 영향을 미치지 않았다. 이러한 나노 크기 벌 화분의 약리 효능은 dutasteride의 효과와 유사하였다. 마지막으로 나노 크기의 벌 화분은 androgen-반응성 인간 전립선 샘암종 세포인 LNCaP 세포의 손상을 유도하지 않았다. 이러한 결과를 종합하면, 나노화 된 벌 화분은 양성전립선비대증의 치료에 대체요법으로 이용될 수 있을 것으로 기대된다.

Bee pollen is one of many types of alternative remedies, and it has been used for a long time throughout the world. It has numerous health effects, including antifungal, antibacterial, and antioxidant properties, immune modulation, enhanced cell proliferation, and even anti-carcinogenic effects. This study was designed to elucidate the effects of bee pollen on benign prostatic hyperplasia in rodents. For this experiment, we used nano-sized bee pollen produced through wet-grinding technology, thereby the extraction efficiency of the active ingredients in the bee pollen was significantly enhanced. First, We found that nano-sized bee pollen significantly reduced the size of prostates enlarged by chronic testosterone administration. In addition, nano-sized bee pollen significantly reduced the plasma concentration of the prostate-specific antigen (PSA). Interestingly, nano-sized bee pollen did not reduce the testosterone-induced increase in the plasma concentration of prostaglandin $E_2$ ($PGE_2$). The beneficial effects of nano-sized bee pollen in reducing both the size of the prostate and the plasma concentration of PSA was comparable to that of dutasteride. Finally, nano-sized bee pollen did not cause damage in LNCaP cells which are androgen-sensitive human prostate adenocarcinoma cells. Together, these data indicate that nano-sized bee pollen may be able to be used as a good alternative remedy for the treatment of benign prostatic hyperplasia.

키워드

참고문헌

  1. Ares, A. M., Valverde, S., Bernal, J. L., Nozal, M. J. and Bernal, J. 2018. Extraction and determination of bioactive compounds from bee pollen. J. Pharm. Biomed. Anal. 147, 110-124. https://doi.org/10.1016/j.jpba.2017.08.009
  2. Baltrusaityte, V., Venskutonis, P. R. and Ckstaryte, V. 2007. Radical scavenging activity of different floral origin honey and beebread phenolic extracts. Food Chem. 101, 502. https://doi.org/10.1016/j.foodchem.2006.02.007
  3. Bogdanov, S. 2015. Pollen: production, nutrition and health: A review. www.bee-hexagon.net.
  4. Buck, A. C. 1996. Phytotherapy for the prostate. Br. J. Urol. 78, 325-326. https://doi.org/10.1046/j.1464-410X.1996.00104.x
  5. Choi, Y. S., Suh, H. J. and Chung, I. K. 2016. Enhanced extraction of bioactive compounds from bee pollen by wetgrinding technology. J. Life Sci. 6, 651-656.
  6. Cohen, S. A. and Parsons, J. K. 2012. Combination pharmacological therapies for the management of benign prostatic hyperplasia. Drugs Aging 29, 275-284. https://doi.org/10.2165/11598600-000000000-00000
  7. Cordaro, M., Impellizzeri, D., Siracusa, R., Gugliandolo, E., Fusco, R., Inferrera, A., Esposito, E., Di Paola, R. and Cuzzocrea, S. 2017. Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia. Toxicol. Appl. Pharmacol. 329, 231-240. https://doi.org/10.1016/j.taap.2017.06.005
  8. Kim, S. B., Jo, Y. H., Liu, Q., Ahn, J. H., Hong, I. P., Han, S. M., Hwang, B. Y. and Lee, M. K. 2015. Optimization of extraction condition of bee pollen using response surface methodology: correlation between anti-melanogenesis, antioxidant Activity, and phenolic content. Molecules 20, 19764-19774. https://doi.org/10.3390/molecules201119656
  9. Komosinska-Vassev, K., Olczyk, P., Kazmierczak, J., Mencner, L. and Olczyk, K. 2015. Bee pollen: chemical composition and therapeutic application. Evid. Based Complement Alternat. Med. 2015, 297425.
  10. MacDonald, R., Ishani, A., Rutks, I. and Wilt, T. J. 2000. A systematic review of Cernilton for the treatment of benign prostatic hyperplasia. BJU Int. 85, 836-841.
  11. McNicholas, T. and Kirby, R. 2011. Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS). BMJ Clin. Evid. 26, 2011.
  12. Morais, M., Moreira, L., Feás, X. and Estevinho, L. M. 2011. Honeybee-collected pollen from five Portuguese Natural Parks: Palynological origin, phenolic content, antioxidant properties and antimicrobial activity. Food Chem. Toxicol. 39, 1096.
  13. Nickel, J. C. 2006. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis. Curr. Opin. Urol. 16, 5-10. https://doi.org/10.1097/01.mou.0000193365.46081.cd
  14. Pyeon, H. I., Bak, J., Seok, J. I., So, S., Suh, H. J., Oh, M., Kim, S., Yang, C. E., Chung, I. K. and Choi, Y. S. 2017. Effects of nano-sized bee pollen as a new cosmetic ingredient. Asian J. Beauty Cosmetol. 15, 1-9. https://doi.org/10.20402/ajbc.2016.0078
  15. Swaroop, A., Bagchi, M., Kumar, P., Preuss, H. G. and Bagchi, D. 2015. Safety and efficacy of a novel Prunus domestica extract (Sitoprin, CR002) on testosterone-induced benign prostatic hyperplasia (BPH) in male Wistar rats. Toxicol. Mech. Methods 25, 653-664. https://doi.org/10.3109/15376516.2015.1077362
  16. Ulbricht, C., Conquer, J., Giese, N., Khalsa, K. P., Sklar, J., Weissner, W. and Woods, J. 2009. An evidence-based systematic review of bee pollen by the Natural Standard Research Collaboration. J. Diet Suppl. 6, 290-312. https://doi.org/10.1080/19390210903081381
  17. Van Asseldonk, B., Barkin, J. and Elterman, D. S. 2015. Medical therapy for benign prostatic hyperplasia: a review. Can. J. Urol. 22, Suppl 1:7-17.
  18. Wu, Y. D. and Lou, Y. J. 2007. A steroid fraction of chloroform extract from bee pollen of Brassica campestris induces apoptosis in human prostate cancer PC-3 cells. Phytother. Res. 21, 1087-1091. https://doi.org/10.1002/ptr.2235